Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Hemophilia Type A or Type B
- Adults aged 18 years or older
- People who are currently using regular or on-demand treatment to replace clotting factors, or using a non-factor based replacement treatment
- People who are able to walk at least 20 meters on their own, with or without a walking aid such as a cane or frame
- People who have agreed to take part in the study by signing a consent form
Who may not be able to join:
- People who have serious health conditions affecting the heart, lungs, nervous system, or muscles and bones
- People who are unable to complete the study assessments due to a physical disability or difficulty with the language used in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ruud Knols, PhD, University of Zurich
Phone: 0442558809
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Short Physical Performance Battery (SPPB); Four Square Step Test (FSST); Timed up and Go (TUG); Unipedal Stance Test (UST); 30-Second Stair Stand Test; 1 kg Arm Lift Test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.